Assembly Biosciences ASMB
NASDAQ ASMB
$36.60 +0.47 (+1.30%)
As of: Sep 4, 2026 · 3:59 PM EDT

Assembly Biosciences (ASMB) EV to FCF (2010 - 2026)

Analysis

Assembly Biosciences (ASMB) EV to FCF (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Assembly Biosciences 689.29 Mn 368.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.44
Mar 31, 2026 -9.69
Dec 31, 2025 9.37
Sep 30, 2025 -6.08
Jun 30, 2025 -3.82
Mar 31, 2025 0.78
Dec 31, 2024 42.57
Sep 30, 2024 -0.08
Jun 30, 2024 1.29
Mar 31, 2024 2.18
Dec 31, 2023 -1.03
Sep 30, 2023 -0.03
Jun 30, 2023 -0.04
Mar 31, 2023 1.28
Dec 31, 2022 1.53
Sep 30, 2022 1.46
Jun 30, 2022 0.87
Mar 31, 2022 0.85
Dec 31, 2021 1.80
Sep 30, 2021 1.51